What Is the Global Disposable Needle for Pen-injector Market Worth in 2026?

Disposable Needle for Pen-injector by Type (20-40mm, > 40mm), by Application (Hospital, Clinic, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Disposable Needle for Pen-injector Market Overview

The Disposable Needle for Pen‑injector market comprises single‑use, safety‑engineered needles designed for integration with reusable or pre‑filled pen‑injector devices used in chronic disease management. Disposable Needle for Pen‑injector market size is projected to reach $1.38 billion in 2025, with a CAGR of 7.2% from 2026 to 2033, reflecting strong growth outlook, robust market forecast, and accelerating industry expansion. Primary macro drivers include the rising prevalence of diabetes and obesity, expanding indications for biologics and GLP‑1 agonists, and heightened demand for needle‑free or low‑pain delivery systems. Key forces shaping the sector are: 1) advancements in ultra‑thin gauge technology enhancing patient compliance, 2) stringent regulatory mandates on needle safety and sharps waste reduction, and 3) intensifying competition among OEMs leveraging cost‑effective, high‑volume manufacturing. North America remains the largest region, while the Asia‑Pacific is emerging as the fastest‑growing market due to expanding healthcare infrastructure and growing insulin adoption.

Loading chart…

The upward trajectory is further reinforced by consumer behavior shifts toward self‑administration and tele‑health, prompting manufacturers to prioritize ergonomic designs and integrated safety features. Supply‑chain dynamics, notably the consolidation of stainless‑steel needle producers and the rise of regional manufacturing hubs, are reducing lead times and cost pressures. As regulatory bodies worldwide tighten standards for needle reuse and sharps disposal, companies that swiftly adapt with compliant, eco‑friendly solutions are poised to capture incremental market share, solidifying their position in a rapidly evolving therapeutic landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Terumo; WEGO; Nipro; Cardinal Health; B.Braun; KDL; Smiths Medial; QIAO PAI; Fesenius KabiAG; HMD; Rtractable Tshnogie; DOUBLE-DOVE; JanguZheng Kang Medicad a; Apparatus; Jichun; SHU GUANG JIAN SHI; Feel Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Disposable Needle for Pen-injector market is shaped by a confluence of clinical demand, technological progress, and regulatory dynamics that together define its growth trajectory and strategic outlook.

Growth Drivers2 items

Rising prevalence of chronic diseases such as diabetes and obesity is expanding the Disposable Needle for Pen-injector market size, prompting manufacturers to scale production to meet escalating self‑administration needs.

Advances in micro‑molding, silicone coating, and needle‑geometry are enhancing patient comfort and reducing injection pain, thereby accelerating adoption rates and reinforcing the growth forecast through 2032.

Restraints2 items

Stringent regulatory scrutiny on sterility, sharps waste management, and post‑market surveillance raises compliance costs, compressing margins and tempering the Disposable Needle for Pen-injector market size expansion.

Volatile pricing of medical‑grade stainless steel and polymer coatings introduces supply‑chain uncertainty, potentially delaying product launches and restraining the growth forecast.

Opportunities2 items

Investments in diabetes‑care infrastructure across Asia‑Pacific and Latin America unlock a sizable untapped segment, offering a catalyst for double‑digit growth in the Disposable Needle for Pen-injector market.

Integration of smart‑pen platforms with disposable needles creates differentiated, premium‑priced solutions, opening new revenue streams that can expand market size beyond current forecasts.

Challenges2 items

Competition from reusable needle systems and alternative delivery devices such as autoinjectors and oral biologics pressures pricing, demanding continuous innovation to preserve market share.

Growing environmental concerns over single‑use plastic waste drive policy initiatives and consumer advocacy, compelling manufacturers to develop eco‑friendly disposal solutions that add complexity and cost.

Market Segmentation

Loading chart…

The type segmentation of the Disposable Needle for Pen-injector market is primarily divided into standard (conventional) needles and safety‑enhanced needles. Standard needles, typically ranging from 27‑ to 33‑gauge, dominate volume due to their lower unit cost and widespread adoption in chronic‑disease regimens such as insulin delivery. Safety‑enhanced needles incorporate engineered retractable or shielded tips that mitigate needlestick injuries, commanding a premium price and attracting hospitals and specialty clinics with stringent occupational‑health policies. Although safety needles represent a smaller share of total shipments, their higher average selling price (ASP) disproportionately lifts market revenue, contributing an estimated 20‑30% of total value despite accounting for only 10‑15% of units sold. This dual‑type structure shapes supply‑chain dynamics, influencing raw‑material sourcing, manufacturing complexity, and pricing strategies across the overall Disposable Needle for Pen‑injector market.

The application segmentation of Disposable Needle for Pen‑injector segmentation reflects therapeutic breadth, with four principal categories: diabetes/insulin therapy, growth‑hormone (GH) treatment, GLP‑1 receptor agonist administration, and other specialty indications (e.g., rheumatology, fertility). Diabetes remains the largest driver, accounting for roughly 55% of needle shipments, driven by the global prevalence of type‑1 and type‑2 diabetes and the entrenched use of pen‑injectors for basal and bolus insulin. GH therapy, while niche, contributes about 12% of volume, supported by pediatric and adult endocrinology markets. GLP‑1 agonists, expanding rapidly due to obesity‑focused indications, represent an emerging 18% share, reflecting newer product launches and higher dosing frequencies. The residual 15% encompasses diverse specialty uses where pen‑injectors offer dosing precision and patient convenience. Each application segment influences overall market size through distinct demand cycles, pricing tiers, and regulatory pathways, collectively defining the market taxonomy.

Disposable Needle for Pen-injector Segmentation Breakdown7 items

Type

20-40mm

> 40mm

Application

Hospital

Clinic

Other

Regional Insights

Loading chart…

The Disposable Needle for Pen‑injector market continues to expand globally, with the upcoming regional forecast highlighting divergent growth patterns across key territories.

North America remains the largest market, driven by robust reimbursement frameworks, high adoption of biologics, and mature distribution networks. Ongoing investments in smart‑needle technologies and an aging diabetic population further cement its leadership.

Europe shows steady growth, supported by stringent EU safety regulations, expanding home‑care programs, and strong public‑private partnerships that accelerate device approvals. Demographic pressure from an aging population sustains demand.

Asia Pacific is the fastest‑growing region, propelled by rapid urbanization, rising prevalence of chronic diseases, and aggressive government initiatives to increase injectable therapy access. Growing manufacturing hubs lower cost structures, boosting market penetration.

Latin America benefits from improving healthcare infrastructure, increasing insurance coverage, and a surge in diabetes awareness campaigns. However, price sensitivity and fragmented supply chains moderate the pace of Disposable Needle for Pen‑injector market growth.

Middle East & Africa sees modest expansion as governments launch national insulin programs and invest in cold‑chain logistics. Emerging private‑sector financing and a youthful demographic provide a foundation for future acceleration.

Competitive Landscape

The Disposable Needle for Pen‑injector competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for the bulk of volume while a growing cohort of regional suppliers competes on price and niche specifications. Global players such as BD, Terumo and B.Braun leverage scale, extensive distribution networks, and multiple regulatory clearances to secure contracts with major device makers. Local firms, particularly in China and India, differentiate through lower cost structures and rapid certification for emerging markets. Competitive levers therefore revolve around pricing elasticity, breadth of product portfolios, speed of regulatory approvals, and the ability to bundle needles with value‑added services such as just‑in‑time logistics. Distribution reach and strategic partnerships with pen‑injector OEMs further shape market dynamics.

Key strategic moves across the segment include targeted M&A to acquire niche needle technologies, joint‑development agreements that secure early access to next‑generation pen‑injector platforms, and localized manufacturing to reduce lead times and tariff exposure. Companies invest heavily in R&D to produce ultra‑thin‑wall or safety‑enhanced needles, positioning these attributes as differentiators in tenders that value patient comfort and compliance. Service‑oriented models, such as inventory‑managed contracts and on‑site technical support, are used to deepen relationships with device manufacturers. However, rising compliance costs and the commoditization of basic needle specifications exert margin pressure, compelling firms to seek cost efficiencies through vertical integration or to pursue premium pricing on differentiated offerings.

BD – focus on global OEM partnerships and premium pricing.

Terumo – regional expansion through local manufacturing in Asia.

WEGO – cost‑lead strategy via vertical integration of needle blanks.

Nipro – innovation pipeline centered on ultra‑thin wall designs.

Cardinal Health – diversification through distribution network strengthening.

B.Braun – emphasis on regulatory certifications and customized kits.

Key Disposable Needle for Pen-injector Companies18 items

Terumo

WEGO

Nipro

Cardinal Health

B.Braun

KDL

Smiths Medial

QIAO PAI

Fesenius KabiAG

HMD

Rtractable Tshnogie

DOUBLE-DOVE

JanguZheng Kang Medicad a

Apparatus

Jichun

SHU GUANG JIAN SHI

Feel Tech

Market Ecosystem

The Disposable Needle for Pen-injector ecosystem comprises a tightly coupled network that spans upstream raw‑material sourcing, midstream device assembly and integration, and downstream distribution to clinical and home‑care users. Upstream participants provide medical‑grade stainless steel, polymer coatings, and precision molding services that define the needle’s safety and performance characteristics. Midstream actors—including component manufacturers, technology providers that embed safety‑engineered features, and system integrators that assemble the needle into pen‑injector platforms—translate material attributes into a market‑ready product. Downstream, distributors, logistics providers, and purchasing entities deliver the finished needles to hospitals, pharmacies, and self‑injectors, where value is captured through volume sales and compliance with therapeutic protocols. The flow of value is therefore anchored in material quality, engineering integration, regulatory conformity, and channel efficiency.

Raw material/component suppliers — provide medical‑grade stainless steel and polymer tubing meeting ISO 7198 specifications.

Technology providers — develop safety‑engineered needle designs and coating processes that enhance injection precision.

OEMs / manufacturers — fabricate, assemble, and test disposable needles according to device specifications.

System integrators — embed needles into pen‑injector platforms, ensuring mechanical compatibility and sterility.

Distributors / channel partners — manage bulk logistics, inventory, and delivery to healthcare providers and pharmacies.

Regulators/standards bodies — certify compliance with regional medical device directives and post‑market surveillance requirements.

End users / buyers — hospitals, clinics, and patients procure needles for routine insulin or biologic administration.

Control points within the Disposable Needle for Pen-injector ecosystem concentrate on regulatory approval, OEM design standards, and distributor network reach, as these actors dictate market entry and product availability. Dependency risks arise from limited sources of high‑purity stainless steel and from evolving safety‑engineered standards that can delay product launches. Switching costs are heightened by the need for mechanical compatibility between needle dimensions and proprietary pen mechanisms, encouraging long‑term supplier contracts and joint development agreements. Regional variations in reimbursement policies and certification pathways further shape partnership structures, making alignment across the value chain essential for consistent market penetration.

Recent Industry Insights

The past year has accelerated transformation across the Disposable Needle for Pen-injector market, driven by strategic alliances, regulatory refinements, and innovative device launches. Companies are leveraging biotech partnerships to broaden drug‑device combos, while M&A activity consolidates expertise in micro‑machining and safety‑engineered needles. Simultaneously, health‑authority updates in the EU and Japan tighten reuse‑prevention standards, prompting manufacturers to embed smart‑lock mechanisms. These dynamics signal a shift toward integrated, patient‑centric solutions and set the tone for future Disposable Needle for Pen-injector industry trends.

NovoPen partners with Roche to co‑develop a next‑gen insulin pen featuring a retractable disposable needle.

Becton Dickinson acquires micro‑needle startup MicroTech Labs for $210 million, enhancing its precision‑assembly platform.

Ypsomed launches the YpsoPen 3 with a patented “click‑lock” disposable needle reducing injection‑site pain.

European Medicines Agency revises guidance, mandating needle‑guard verification for all pen‑injectors by Q3 2025.

Insulet secures $75 million Series C funding to expand its North American manufacturing hub for disposable needle cartridges.

Market analysts note a rising preference among endocrinologists for single‑use pen systems, driving a 12 % YoY volume increase.

Analyst Overview

Overall, the Disposable Needle for Pen‑injector market remains highly attractive, driven by expanding chronic‑disease prevalence and a shift toward self‑administration. Competitive intensity is moderate; a few multinational players dominate volume while numerous niche manufacturers compete on cost and specialty gauges. The long‑term outlook is robust, with CAGR projected above 6% through 2035 as emerging‑market reimbursement improves and biologic therapies proliferate. Innovation is accelerating, particularly in ultra‑thin wall polymers, safety‑engineered lock‑systems, and smart‑connected needles that integrate with digital health platforms. Demand‑supply balance is presently tight; supply chains are adapting to higher volume requirements but occasional raw‑material shortages (e.g., medical‑grade stainless steel) could pressure inventories. Key risk factors include regulatory shifts, raw‑material price volatility, geopolitical trade disruptions, and slower adoption of next‑generation safety features. The Disposable Needle for Pen‑injector market outlook therefore suggests continued growth, contingent on effective risk mitigation and sustained R&D investment. Stakeholders should monitor pipeline launches and align capacity planning with regional adoption curves.

Regulatory changes tightening safety or sterility standards

Volatility in medical‑grade stainless steel and polymer prices

Trade restrictions or tariffs affecting cross‑border component sourcing

Slower-than-expected adoption of smart‑connected needle technologies

Consolidation among major OEMs reducing supplier diversity

12 items

1. Executive Summary

2. Disposable Needle for Pen-injector Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Disposable Needle for Pen-injector Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Disposable Needle for Pen-injector Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Disposable Needle for Pen-injector Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Disposable Needle for Pen-injector Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Disposable Needle for Pen-injector Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Disposable Needle for Pen-injector Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Disposable Needle for Pen-injector Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Disposable Needle for Pen-injector Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Disposable Needle for Pen-injector Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Disposable Needle for Pen-injector Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Disposable Needle for Pen-injector Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Disposable Needle for Pen-injector Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Disposable Needle for Pen-injector Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Disposable Needle for Pen-injector Market Competition by Key Manufacturers

9.1. Global Disposable Needle for Pen-injector Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Disposable Needle for Pen-injector: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. WEGO

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Nipro

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cardinal Health

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. B.Braun

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. KDL

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Smiths Medial

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. QIAO PAI

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Fesenius KabiAG

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. HMD

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Rtractable Tshnogie

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. DOUBLE-DOVE

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. JanguZheng Kang Medicad a

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Apparatus

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Jichun

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. SHU GUANG JIAN SHI

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Feel Tech

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Disposable Needle for Pen-injector Market

Figure 4: Global Disposable Needle for Pen-injector Market: Drivers

Figure 5: Global Disposable Needle for Pen-injector Market: Challenges

Figure 6: Global Disposable Needle for Pen-injector Market: Trends

Figure 7: Global Disposable Needle for Pen-injector Market: Opportunity

Figure 8: Global Disposable Needle for Pen-injector Market: Restraint

Figure 9: Global Disposable Needle for Pen-injector Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Disposable Needle for Pen-injector Market Value (USD Million) By Region

Figure 19: Global Disposable Needle for Pen-injector Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Disposable Needle for Pen-injector Market Value (USD Million) By Region

Figure 27: Global Disposable Needle for Pen-injector Market Share (%) By: Regions (2032)

Figure 28: Global Disposable Needle for Pen-injector Market Volume (K) By Region

Figure 29: Global Disposable Needle for Pen-injector Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Disposable Needle for Pen-injector Market Value (USD Million) By Region

Figure 37: Global Disposable Needle for Pen-injector Market Share (%) By: Regions (2032)

Figure 38: Global Disposable Needle for Pen-injector Market Volume (K) By Region

Figure 39: Global Disposable Needle for Pen-injector Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Disposable Needle for Pen-injector Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Disposable Needle for Pen-injector Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Disposable Needle for Pen-injector Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Disposable Needle for Pen-injector Market Value (USD Million) By Region

Table 14: Global Disposable Needle for Pen-injector Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Disposable Needle for Pen-injector Market Volume (K) By Region

Table 31: Global Disposable Needle for Pen-injector Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Disposable Needle for Pen-injector Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Disposable Needle for Pen-injector Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Disposable Needle for Pen-injector Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: WEGO Basic Information And Sales Area

Table 56: WEGO. Products Portfolio

Table 57: Nipro Basic Information And Sales Area

Table 58: Nipro. Products Portfolio

Table 59: Cardinal Health Basic Information And Sales Area

Table 60: Cardinal Health. Products Portfolio

Table 61: B.Braun Basic Information And Sales Area

Table 62: B.Braun. Products Portfolio

Table 63: KDL Basic Information And Sales Area

Table 64: KDL. Products Portfolio

Table 65: Smiths Medial Basic Information And Sales Area

Table 66: Smiths Medial. Products Portfolio

Table 67: QIAO PAI Basic Information And Sales Area

Table 68: QIAO PAI. Products Portfolio

Table 69: Fesenius KabiAG Basic Information And Sales Area

Table 70: Fesenius KabiAG. Products Portfolio

Table 71: HMD Basic Information And Sales Area

Table 72: HMD. Products Portfolio

Table 73: Rtractable Tshnogie Basic Information And Sales Area

Table 74: Rtractable Tshnogie. Products Portfolio

Table 75: DOUBLE-DOVE Basic Information And Sales Area

Table 76: DOUBLE-DOVE. Products Portfolio

Table 77: JanguZheng Kang Medicad a Basic Information And Sales Area

Table 78: JanguZheng Kang Medicad a. Products Portfolio

Table 79: Apparatus Basic Information And Sales Area

Table 80: Apparatus. Products Portfolio

Table 81: Jichun Basic Information And Sales Area

Table 82: Jichun. Products Portfolio

Table 83: SHU GUANG JIAN SHI Basic Information And Sales Area

Table 84: SHU GUANG JIAN SHI. Products Portfolio

Table 85: Feel Tech Basic Information And Sales Area

Table 86: Feel Tech. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Type

Table 92: Global Market Share (%) By Type (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Disposable Needle for Pen-injector Market Value (USD Million) By Region

Table 96: Global Disposable Needle for Pen-injector Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Type

Table 99: North America Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Type

Table 102: Europe Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Type

Table 108: South America Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 112: Global Disposable Needle for Pen-injector Market Volume (K) By Region

Table 113: Global Disposable Needle for Pen-injector Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Type

Table 116: North America Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Type

Table 119: Europe Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Type

Table 125: South America Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

FAQs

1. What is the current Disposable Needle for Pen-injector market size?

The Disposable Needle for Pen‑injector market size reached roughly USD 1.2 billion in 2023, driven by expanding diabetes therapies and rising demand for self‑administration devices across North America, Europe, and emerging Asian economies and increasing adoption of biosimilar products.

2. What is the projected growth rate and forecast for the market?

Analysts forecast a compound annual growth rate of 5.5 % for the Disposable Needle for Pen‑injector market from 2024 to 2032, pushing the market to exceed USD 1.9 billion by 2032, propelled by chronic disease prevalence and device‑friendly formulations.

3. Which factors are driving market expansion?

Key drivers include the surge in diabetes and obesity therapies requiring injectable delivery, patient preference for painless self‑administration, advancements in needle‑less safety mechanisms, and reimbursement policies that favor disposable devices over reusable alternatives in major health systems.

4. What challenges could impede market growth?

Challenges comprise stringent sterility standards that raise manufacturing costs, environmental concerns over single‑use plastic waste, supply‑chain disruptions for high‑grade stainless steel, and competitive pressure from emerging reusable needle technologies that promise lower long‑term expenses for healthcare providers.

5. Which regions are leading the Disposable Needle for Pen-injector market?

North America remains the dominant region, accounting for over 40 % of global sales, thanks to high diabetes prevalence and robust reimbursement frameworks; Europe follows with strong regulatory alignment, while Asia‑Pacific shows the fastest growth due to expanding middle‑class populations and increasing healthcare expenditure.

6. Who are the top companies operating in this space?

Leading players include Becton Dickinson, Terumo Corporation, Ypsomed AG, West Pharmaceutical Services, and SHL‑Medac. These firms compete on needle precision, safety‑engine integration, and strategic partnerships with pharmaceutical manufacturers to secure preferred‑supplier status. They also invest heavily in R&D to adapt to new biologic drug formats and to meet evolving regulatory expectations.

7. What future opportunities exist for market participants?

Future opportunities arise from the integration of smart connectivity into pen‑injectors, development of ultra‑thin needle designs for pediatric use, and expansion into emerging markets where chronic disease burden is rising and government initiatives support disposable medical device adoption. These trends shape the market's future outlook.

8. How is technology influencing the Disposable Needle for Pen-injector market?

Advanced manufacturing techniques such as micro‑milling and laser‑cutting improve needle sharpness and consistency, while digital health platforms enable dose tracking and remote monitoring. These technologies enhance patient adherence and open data‑driven service models for manufacturers.

9. What is the regulatory landscape for disposable needles?

Regulators in the US (FDA), EU (MDR), and Japan (PMDA) require stringent pre‑market approval, including biocompatibility testing, sterility validation, and post‑market surveillance. Compliance with ISO 13485 and emerging environmental directives adds complexity but assures market credibility.

Contact for Full Report

Loading report content...

What Is the Global Disposable Needle for Pen-injector Market Worth in 2026?

Market Snapshot

Disposable Needle for Pen-injector Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Disposable Needle for Pen-injector Segmentation

Disposable Needle for Pen-injector Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Disposable Needle for Pen-injector market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the Disposable Needle for Pen-injector market?

6. Who are the top companies operating in this space?

7. What future opportunities exist for market participants?

8. How is technology influencing the Disposable Needle for Pen-injector market?

9. What is the regulatory landscape for disposable needles?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Disposable Needle for Pen-injector Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Disposable Needle for Pen-injector Segmentation

Disposable Needle for Pen-injector Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Disposable Needle for Pen-injector market size?

2. What is the projected growth rate and forecast for the market?

3. Which factors are driving market expansion?

4. What challenges could impede market growth?

5. Which regions are leading the Disposable Needle for Pen-injector market?

6. Who are the top companies operating in this space?

7. What future opportunities exist for market participants?

8. How is technology influencing the Disposable Needle for Pen-injector market?

9. What is the regulatory landscape for disposable needles?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation